Related Experiment Videos
p53 and pRb prevent rereplication in response to microtubule inhibitors by mediating a reversible G1 arrest
1Department of Biology, University of California at San Diego, La Jolla 92037, USA.
Abstract:
Cell cycle checkpoints are safeguards that ensure the initiation of downstream events only after completion of upstream processes. The tumor suppressors p53 and pRb prevent initiation of a second round of replication in response to spindle inhibitors, but it has yet to be proven that this is a mitotic checkpoint response. We show that asynchronous human fibroblasts arrest in G1 with 4 N DNA content after nocodazole treatment, whereas isogenic p53- and pRb-deficient fibroblasts rereplicate. Importantly, nocodazole elicits a reversible arrest in G0-G1 synchronized normal human fibroblasts but not in isogenic p53-deficient derivatives. Furthermore, the G1 cyclin-dependent kinase inhibitors p21 and p16 also play critical roles in limiting rereplication. Hence, p53 and pRb are required during G1 to prevent entry into a replicative cycle and appear to provide a connection between the structural integrity of the microtubules and the cell cycle machinery in interphase cells.
Insights
Tumor suppressors p53 and pRb prevent cell rereplication after microtubule damage. These proteins, along with p21 and p16, are crucial for G1 arrest, ensuring genomic stability.
Area of Science:
- Cell Biology
- Molecular Biology
- Cancer Research
Background:
- Cell cycle checkpoints are critical for preventing DNA replication errors.
- The roles of tumor suppressors p53 and pRb in response to spindle damage are not fully understood.
- Previous studies suggest p53 and pRb involvement in mitotic checkpoint responses.
Purpose of the Study:
- To investigate the role of p53 and pRb in preventing rereplication upon microtubule disruption.
- To determine if the observed arrest is a mitotic checkpoint response.
- To elucidate the involvement of G1 cyclin-dependent kinase inhibitors in this process.
Main Methods:
- Treatment of asynchronous and synchronized human fibroblasts with nocodazole (a spindle inhibitor).
- Analysis of DNA content and cell cycle progression in wild-type and isogenic p53/pRb-deficient fibroblasts.
- Assessment of the roles of p21 and p16 in regulating rereplication.
Main Results:
- Nocodazole treatment caused G1 arrest with 4N DNA content in normal fibroblasts, but rereplication occurred in p53- and pRb-deficient cells.
- Normal fibroblasts synchronized in G0-G1 arrested reversibly upon nocodazole treatment, unlike p53-deficient cells.
- p21 and p16 were identified as key inhibitors of rereplication in G1.
Conclusions:
- p53 and pRb are essential in G1 phase to prevent cell rereplication following microtubule damage.
- These tumor suppressors link microtubule integrity to the cell cycle machinery during interphase.
- The findings highlight a non-mitotic checkpoint mechanism involving p53 and pRb for maintaining genomic stability.